Literature DB >> 19778971

Screening for prostate cancer remains controversial.

Jennifer R Stark1, Lorelei Mucci, Kenneth J Rothman, Hans-Olov Adami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19778971     DOI： 10.1136/bmj.b3601

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

1.  Early detection of prostate cancer: is screening in general practice justifiable?

Authors:  Emil L Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2011-08-16       Impact factor: 2.581

2.  Homogeneous prostate cancer mortality in the Nordic countries over four decades.

Authors:  Mara S Meyer; Lorelei A Mucci; Swen-Olof Andersson; Ove Andrén; Jan-Erik Johansson; Steinar Tretli; Hans-Olov Adami
Journal:  Eur Urol       Date:  2010-06-04       Impact factor: 20.096

3.  Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.

Authors:  Anqi Wang; Mariana Lazo; H Ballentine Carter; John D Groopman; William G Nelson; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-03       Impact factor: 4.254

4.  mRNA expression signature of Gleason grade predicts lethal prostate cancer.

Authors:  Kathryn L Penney; Jennifer A Sinnott; Katja Fall; Yudi Pawitan; Yujin Hoshida; Peter Kraft; Jennifer R Stark; Michelangelo Fiorentino; Sven Perner; Stephen Finn; Stefano Calza; Richard Flavin; Matthew L Freedman; Sunita Setlur; Howard D Sesso; Swen-Olof Andersson; Neil Martin; Philip W Kantoff; Jan-Erik Johansson; Hans-Olov Adami; Mark A Rubin; Massimo Loda; Todd R Golub; Ove Andrén; Meir J Stampfer; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  Reversals of association for Pap, colorectal, and prostate cancer testing among Hispanic and non-Hispanic black women and men.

Authors:  William Rakowski; Melissa A Clark; Michelle L Rogers; Sherry H Weitzen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-10       Impact factor: 4.254

Review 6.  Multiplexed detection of molecular biomarkers with phase-change nanoparticles.

Authors:  Ming Su
Journal:  Nanomedicine (Lond)       Date:  2013-02       Impact factor: 5.307

7.  Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of Sweden.

Authors:  Jon Fridriksson; Katarina Gunseus; Pär Stattin
Journal:  Scand J Urol Nephrol       Date:  2012-05-31

8.  A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006.

Authors:  Cynthia Chen; Nasheen Naidoo; Qian Yang; Mikael Hartman; Helena M Verkooijen; En Yun Loy; Christine Bouchardy; Kee Seng Chia; Sin Eng Chia
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

9.  Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.

Authors:  David C Wheeler; Konrad M Szymanski; Amanda Black; David E Nelson
Journal:  BMC Cancer       Date:  2011-04-21       Impact factor: 4.430

10.  Access to cancer screening in people with learning disabilities in the UK: cohort study in the health improvement network, a primary care research database.

Authors:  David P J Osborn; Laura Horsfall; Angela Hassiotis; Irene Petersen; Kate Walters; Irwin Nazareth
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.